mucus relief extended release maximum strength (70000-0479)

Drug Facts

Product Profile

Brand Name mucus relief extended release maximum strength

Generic Name guaifenesin

Labeler cardinal health 110, llc. dba leader 70000

Dosage Form TABLET

Routes

ORAL

Active Ingredients

guaifenesin 1200 mg/1

Manufacturer

CARDINAL HEALTH 110, LLC. DBA LEADER 70000

Identifiers & Regulatory

Product NDC 70000-0479

Product ID 70000-0479_df386042-7796-4e24-9f8e-39ea465065ad

Product Type HUMAN OTC DRUG

Marketing Category ANDA

Application Number ANDA207342

Marketing Start 2019-01-31

Marketing End 2027-03-28

Pharmacologic Class

Established (EPC)

expectorant [epc]

Physiologic Effect

decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 700000479

Hyphenated Format 70000-0479

Supplemental Identifiers

RxCUI

310621

UPC

0096295136845

UNII

495W7451VQ

NUI

N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mucus relief extended release maximum strength (source: ndc)

Generic Name guaifenesin (source: ndc)

Application Number ANDA207342 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

1200 mg/1

source: ndc

Packaging

14 BLISTER PACK in 1 CARTON (70000-0479-1) / 1 TABLET in 1 BLISTER PACK
28 BLISTER PACK in 1 CARTON (70000-0479-2) / 1 TABLET in 1 BLISTER PACK

source: ndc

Packages (2)

70000-0479-1 14 BLISTER PACK in 1 CARTON (70000-0479-1) / 1 TABLET in 1 BLISTER PACK 70000-0479-2 28 BLISTER PACK in 1 CARTON (70000-0479-2) / 1 TABLET in 1 BLISTER PACK

Ingredients (1)

guaifenesin (1200 mg/1)

Linked Drug Pages (1)

Mucus Relief Extended Release Maximum Strength ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "df386042-7796-4e24-9f8e-39ea465065ad", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0096295136845"], "unii": ["495W7451VQ"], "rxcui": ["310621"], "spl_set_id": ["54a59e95-f95a-4bcd-ac9d-8d4ace85277f"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER 70000"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "14 BLISTER PACK in 1 CARTON (70000-0479-1)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "70000-0479-1", "marketing_end_date": "20261028", "marketing_start_date": "20190131"}, {"sample": false, "description": "28 BLISTER PACK in 1 CARTON (70000-0479-2)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "70000-0479-2", "marketing_end_date": "20270328", "marketing_start_date": "20190131"}], "brand_name": "Mucus Relief Extended Release Maximum Strength", "product_id": "70000-0479_df386042-7796-4e24-9f8e-39ea465065ad", "dosage_form": "TABLET", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "70000-0479", "generic_name": "Guaifenesin", "labeler_name": "CARDINAL HEALTH 110, LLC. DBA LEADER 70000", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mucus Relief Extended Release", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA207342", "marketing_category": "ANDA", "marketing_end_date": "20270328", "marketing_start_date": "20190131"}